M1 Kliniken AG
M1 Kliniken AG is one of the fastest growing and leading private providers of health services in the beauty sector. With its products and services, the group of companies offers a customer-oriented spectrum of aesthetic and surgical treatments throughout Germany. The experienced and highly specialised team of employees performs minimally invasive and surgical procedures at the highest qualitative standards using high-quality products and state-of-the-art medical technology.
M1 Kliniken AG is listed on the Frankfurt Stock Exchange in the Open Market under ISIN: DE000A0STSQ8 / WKN: A0STSQ.
HAEMATO AG is a pharmaceutical company whose focus is on the growth markets of off-patent and patent-protected drugs. With its range of generics as well as parallel and re-imports with a focus on the therapeutic areas of oncology, HIV and other chronic diseases, HAEMATO makes an active contribution to reducing costs in the German healthcare system.
On 1 July 2020, M1 Kliniken AG acquired all shares in HAEMATO AG owned by MPH Health Care AG. This transaction will enable M1 Kliniken AG and HAEMATO AG to strengthen their respective core competences. Thus, the M1 Group will in future concentrate on the operation of the beauty clinics as well as the outpatient medical specialist centres and the further growth of the international network. HAEMATO AG will focus even more on the area of drug and medical product trading as well as the development of own brands in the self-pay sector.
HAEMATO AG is listed on the Frankfurt Stock Exchange in the Open Market under ISIN: DE000A289VV1 / WKN: A289VV.
Real estate industry
CR Capital AG
CR Capital AG invests as an integrated investment manager in innovative companies along the real estate value chain. With its holdings "TERRABAU GmbH", "CR Global Care GmbH" and "CR Financial Services", CR Capital AG creates a holistic investment concept with added value for its shareholders. The focus of the business activities lies in the creation of high-quality residential properties in solid construction at affordable prices. In doing so, CR Capital AG relies on ecological construction methods and benefits from just-in-time production, efficient construction costs, short property holding periods and the scalability of the business model. Due to the closed value chain, a high degree of market independence is also achieved.
CR Capital AG is listed on the Frankfurt Stock Exchange in the Open Market under ISIN: DE000A2GS625 / WKN: A2GS62.
For exact figures, please refer to our current annual report.